Corp. Note Aurobindo Pharma Ltd - 524804 - Closure of Trading Window BSE India This is to inform that as per the Company's Internal Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the Trading Window for dealing in the securities of the Company would remain closed for the Designated Persons covered under the said Code of the Company with effect from 4th April, 2019 till 48 hours after the declaration of the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2019. The date of Board Meeting for declaration of the financial results of the Company for the Quarter and Year ended on 31st March, 2019 will be intimated in due course.